Shareholders of Genentech Inc initially looked like they would not accept Roche’s cash bid of $89 per share for all the shares of Genentech that it doesn’t already own. Following the takeover announcement on 21 July 2008, Genentech shares were trading above the bid price with an early quote at $93.50.
